Arcutis Biotherapeutics Inc (ARQT) Stock Falls -4.90% This Week: Is It a Good Pick?

Arcutis Biotherapeutics Inc (ARQT) stock is down -88.76% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ARQT stock a score of 33 out of a possible 100.

That rank is influenced by a long-term technical score of 0. ARQT's rank also includes a short-term technical score of 4.

ARQT has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ARQT!

See Full ARQT Report

What's Happening with ARQT Stock Today

Arcutis Biotherapeutics Inc (ARQT) stock is lower by -4.43% while the S&P 500 is down 0% as of 1:06 PM on Monday, Nov 27. ARQT is down -$0.09 from the previous closing price of $2.03 on volume of 2,107,498 shares. Over the past year the S&P 500 is up 15.02% while ARQT is down -88.76%. ARQT lost -$4.37 per share in the over the last 12 months. Click Here to get the full Stock Report for Arcutis Biotherapeutics Inc stock.